/
Pharmaceutical preparations company · DE · FY ends Nov · Revenue $72M · -439.26% margin · -$272M FCF
The business is unprofitable at the operating level (-340.16% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 54.0% YoY with margins expanding 50.4pp.
Negative free cash flow of -$263M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$72M
▲ +54.0% YoY
Net Income (TTM)
-$295M
▼ -36.6% YoY
Op. Margin
-439.26%
▲ +50.4pp YoY
ROIC
-48.31%
▲ +3.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$272M
▼ -44.9% YoY
Op. Cash Flow (TTM)
-$260M
▼ -44.5% YoY
Net Debt
-$482M
Net Cash Position
Cash & Equiv.
$541M
5Y CAGR: +36.3%
Continue Research